• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    InMode Reports Fourth Quarter and Full Year 2023 Financial Results; Quarterly Revenue of $126.8M and Record Full Year Revenue of $492M

    2/13/24 7:00:00 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $INMD alert in real time by email

    YOKNEAM, Israel, Feb. 13, 2024 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the fourth quarter and full year ended December 31, 2023.

    InMode Ltd Logo

    Fourth Quarter 2023 Highlights:

    • Quarterly revenue of $126.8 million, compared to $133.6 in the fourth quarter of 2022.
    • Quarterly revenues from consumables and service of $20.5 million, an increase of 20% compared to the fourth quarter of 2022.
    • Total cash position of $741.6 million as of December 31, 2023, including cash and cash equivalents, marketable securities, and short-term bank deposits.

    Full Year 2023 Highlights:

    • Record full year revenue of $492 million, a year-over-year increase of 8%.
    • Record GAAP net income of $197.9 million, compared to $161.5 million in 2022; record *non-GAAP net income of $221.5 million, compared to $207.5 million in 2022.
    • 18% increase in international (non-U.S.) revenues as compared to 2022.

     

    U.S. GAAP Results

    (U.S. dollars in thousands, except for per share data)



    Q4 2023

    Q4 2022

    FY 2023

    FY 2022

    Revenues

    $126,781

    $133,571

    $492,048

    $454,271

    Gross Margins

    84 %

    84 %

    84 %

    84 %

    Net Income

    $55,165

    $37,708

    $197,919

    $161,520

    Earnings per Diluted Share

    $0.64

    $0.44

    $2.30

    $1.89

    *Non-GAAP Results

    (U.S. dollars in thousands, except for per share data)



             Q4 2023

    Q4 2022

    FY 2023

    FY 2022

    Gross Margins

    84 %

    85 %

    84 %

    84 %

    Net Income

    $61,487

    $66,370

    $221,519

    $207,486

    Earnings per Diluted Share

    $0.71

    $0.78

    $2.57

    $2.42



    *Please refer to "Use of Non-GAAP Financial Measures" below for important information about non-GAAP financial measures. A

    reconciliation between U.S. GAAP and non-GAAP Statement of Income 
    is provided following the financial statements that are

    included in this release. Non-GAAP results exclude share-based compensation adjustments.in 2022
    The Company applied the

    provisions of the amendment to the Investment Law to its exempt profits accrued prior to 2020 and made a one-time payment of

    $12.0 million to the Israeli Tax Authority. In addition, the Company reached agreement with the Israeli Tax Authority under which

    the Company paid during January 2023 approximately $14.3 million on its undistributed exempt income for the year ended

    December 31, 2021. As a result, approximately $313.2 million of the Company's undistributed exempt income for years 2012

    through 2021 may be distributed or used by the Company without being subject to additional corporate tax.

     

    Management Comments

    "In 2023, particularly the latter half, we saw challenges both for InMode and the aesthetics industry, including the surgical aesthetic sector," said Moshe Mizrahy, Chairman and Chief Executive Officer. "However, we successfully introduced two exciting platforms, Define and Envision, which gained substantial market traction.

    "Looking ahead, we plan to launch 2 new platforms this year and believe that our market share will continue to grow as we introduce new and innovative technologies for minimally invasive aesthetics treatments. Our unique technology and continued commitment to bringing new platforms to market are pivotal in establishing InMode as a global leader in the aesthetics medical device industry worldwide," Moshe Mizrahy concluded.

    Fourth Quarter and Full Year 2023 Financial Results

    Total revenues for the fourth quarter of 2023 reached $126.8 million, compared to $133.6 in the fourth quarter of 2022. Total revenues for 2023 were $492 million, an increase of 8% as compared to 2022. This increase was primarily attributable to the growth in our consumables sales and our expansion in international markets, with international revenues growing 18% year over year.

    GAAP gross margin for the fourth quarter of 2023 and 2022 was 84%. *Non-GAAP gross margin for the fourth quarter of 2023 was 84% compared to a gross margin of 85% for the fourth quarter 2022. GAAP and *Non-GAAP gross margin for 2023 and 2022 was 84%.

    GAAP operating margin for the fourth quarter of 2023 was 40%, compared to an operating margin of 45% in the fourth quarter of 2022. *Non-GAAP operating margin for the fourth quarter of 2023 was 45% compared to 50% for the fourth quarter of 2022. GAAP operating margin for 2023 was 40%, compared to the operating margin of 44% in 2022. *Non-GAAP operating margin for 2023 was 45%, compared to the operating margin of 49% in the full year of 2022. This decrease was primarily attributable to higher sales and marketing expenses, mainly because of the addition of new sales representatives, higher travel expenses, as well as investment in direct-to-consumer advertising campaigns and hosting in-person events to support the company's growth projections.

    InMode reported GAAP net income of $55.2 million, or $0.64 per diluted share, in the fourth quarter of 2023, compared to $37.7 million, or $0.44 per diluted share, in the fourth quarter of 2022. On a *non-GAAP basis, InMode reported net income of $61.5 million, or $0.71 per diluted share, in the fourth quarter of 2023, compared to $66.4 million, or $0.78 per diluted share, in the fourth quarter of 2022. GAAP net income of $197.9 million, or $2.3 per diluted share, in 2023. This is compared with GAAP net income of $161.5 million, or $1.89 per diluted share, in 2022. On a *non-GAAP basis, InMode reported net income of $221.5 million, or $2.57 per diluted share, in the full year of 2023, compared to net income of $207.5 million, or $2.42 per diluted share, in the full year of 2022.

    As of December 31, 2023, InMode had cash and cash equivalents, marketable securities, and short-term bank deposits of $741.6 million.

    2024 Financial Outlook

    Management provided an outlook for the full year of 2024 ending December 31, 2024. Based on current estimates, management expects:

    • Revenue between $495 million and $505 million
    • *Non-GAAP gross margin between 83% and 85%
    • *Non-GAAP income from operations between $217 million and $222 million
    • *Non-GAAP earnings per diluted share between $2.53 and $2.57

    This outlook is not a guarantee of future performance and stockholders should not rely on such forward-looking statements. See "Forward-Looking Statements" for additional information.

    *Please refer to "Use of Non-GAAP Financial Measures" below for important information about non-GAAP financial measures. A reconciliation between U.S. GAAP and non-GAAP Statement of Income is provided following the financial statements that are included in this release. Non-GAAP results exclude share-based compensation adjustments. in 2022 The Company applied the provisions of the amendment to the Investment Law to its exempt profits accrued prior to 2020 and made a one-time payment of $12.0 million to the Israeli Tax Authority. In addition, the Company reached agreement with the Israeli Tax Authority under which the Company paid during January 2023 approximately $14.3 million on its undistributed exempt income for the year ended December 31, 2021. As a result, approximately $313.2 million of the Company's undistributed exempt income for years 2012 through 2021 may be distributed or used by the Company without being subject to additional corporate tax.

    The Current Situation in Israel                                           

    Regarding the current situation in Israel, management would like to assure investors that the Company is prioritizing the safety and well-being of its employees, and all its team are safe. InMode doesn't anticipate any significant interruption or delay in production or shipment. InMode's inventory levels globally and in Israel are adequate and include components and subassemblies for at least 6 months.

    Use of Non-GAAP Financial Measures

    In addition to InMode's operating results presented in accordance with GAAP, this release contains certain non-GAAP financial measures including non-GAAP net income, non-GAAP earnings per diluted share, and non-GAAP operating margin. Because these measures are used in InMode's internal analysis of financial and operating performance, management believes they provide investors with greater transparency of its view of InMode's economic performance. Management also believes the presentation of these measures, when analyzed in conjunction with InMode's GAAP operating results, allows investors to more effectively evaluate and compare InMode's performance to that of its peers, although InMode's presentation of its non-GAAP measures may not be strictly comparable to the similarly titled measures of other companies. Schedules reconciling each of these non-GAAP financial measures are provided as a supplement to this release.

    Conference Call Information

    Mr. Moshe Mizrahy, Chairman and Chief Executive Officer, Dr. Michael Kreindel, Co-Founder and Chief Technology Officer, Mr. Yair Malca, Chief Financial Officer, Mr. Shakil Lakhani, President of North America, and Dr. Spero Theodorou, Chief Medical Officer, will host a conference call today, February 13, 2024, at 8:30 a.m. Eastern Time to discuss the fourth quarter 2023 financial results.

    The Company encourages participants to pre-register for the conference call using the following link:  https://dpregister.com/sreg/10185217/fb446e05e4.

    Callers will receive a unique dial-in number upon registration, which enables immediate access to the call. Participants may pre-register at any time, including up to and after the call start time.

    For callers who opt out of pre-registration, please dial one of the following teleconferencing numbers. Please begin by placing your call 10 minutes before the conference call commences. If you are unable to connect using the toll-free number, please try the international dial-in number.

    U.S. Toll-Free Dial-in Number: 1-833-316-0562

    Israel Toll- Free Dial-in Number: 1-80-921-2373

    International Dial-in Number: 1-412-317-5736

    Webcast URL: https://event.choruscall.com/mediaframe/webcast.html?webcastid=6h4ExUgZ

    At:

    8:30 a.m. Eastern Time

    5:30 a.m. Pacific Time

    The conference call will also be webcast live from a link on InMode's website at https://inmodemd.com/investors/events-presentations/. A replay of the conference call will be available from February 13, 2024, at 12 p.m. Eastern Time to February 27, 2024, at 11:59 p.m. Eastern Time. To access the replay, please dial one of the following numbers: 

    Replay Dial-in U.S TOLL-FREE: 1-877-344-7529

    Replay Dial-in Canada TOLL-FREE: 855-669-9658

    Replay Dial-in TOLL/INTERNATIONAL: 1-412-317-0088

    Replay Pin Number: 6723856

    To access the replay using an international dial-in number, please select the link below:  https://services.choruscall.com/ccforms/replay.html

    A replay of the conference call will also be available for 90 days on InMode's website at https://inmodeinvestors.com/.

    About InMode

    InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.

    Forward-Looking Statements

    The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode's future financial or operating performance, including the 2024 revenue projection described above. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode's Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 14, 2023, and our future public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.

    Company Contact:

    Yair Malca

    Chief Financial Officer

    Phone: (949) 305-0108

    Email: [email protected]

    Investor Relations Contact:

    Miri Segal

    MS-IR LLC

    Phone: (917) 607-8654

    Email: [email protected]

     

     

    INMODE LTD.

    CONDENSED CONSOLIDATED STATEMENTS OF INCOME

    (U.S. dollars in thousands, except for per share data)

    (Unaudited)





    Three months ended 

    December 31,

    Year Ended

    December 31,



    2023

    2022

    2023

    2022



    REVENUES

    126,781

    133,571

    492,048

    454,271



    COST OF REVENUES

    20,264

    21,002

    80,708

    73,485



    GROSS PROFIT

    106,517

    112,569

    411,340

    380,786



    OPERATING EXPENSES:











    Research and development

    3,473

    3,261

    13,410

    12,425



    Sales and marketing

    49,451

    47,012

    193,042

    160,576



    General and administrative

    2,349

    2,398

    9,228

    9,931



    TOTAL OPERATING EXPENSES

    55,273

    52,671

    215,680

    182,932



    INCOME FROM OPERATIONS

    51,244

    59,898

    195,660

    197,854



    Finance income, net

    8,920

    3,962

    21,607

    3,612



    INCOME BEFORE TAXES

    60,164

    63,860

    217,267

    201,466



    INCOME TAXES

    4,999

    26,152

    19,348

    39,946



    NET INCOME

    55,165

    37,708

    197,919

    161,520















    NET INCOME PER SHARE:











    Basic

    0.66

    0.46

    2.37

    1.96



    Diluted

    0.64

    0.44

    2.30

    1.89



    WEIGHTED AVERAGE NUMBER OF SHARES

    OUTSTANDING USED IN COMPUTATION OF NET

    INCOME PER SHARE (in thousands)











    Basic

    83,862

    82,449

    83,534

    82,482



    Diluted

    85,835

    85,288

    85,954

    85,404



     

     



    INMODE LTD.

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (U.S. dollars in thousands, except for per share data)

    (Unaudited)





    December 31,

    2023

    December 31,

    2022

    Assets





    CURRENT ASSETS:





    Cash and cash equivalents

    144,411

    97,540

    Marketable securities (amortized cost of $375,829 and $384,320, as of

     December 31, 2023 and 2022, respectively)

    373,647

    374,589

    Short-term bank deposits

    223,547

    75,254

    Accounts receivable, net of allowance for credit losses of $1,538 and $836,

     as of December 31, 2023 and 2022, respectively

    42,362

    26,997

    Other receivables

    16,268

    15,094

    Inventories

    45,095

    39,897

             TOTAL CURRENT ASSETS

    845,330

    629,371

        NON-CURRENT ASSETS:





    Accounts receivable, net of allowance for credit losses of $716 and $482

     as of December 31, 2023 and 2022, respectively

    3,670

    3,973

    Deferred income tax asset, net

    1,506

    3,094

    Operating lease right-of-use assets

    9,698

    5,073

    Property and equipment, net

    2,382

    2,298

    Other investments

    700

    600

    TOTAL NON-CURRENT ASSETS

    17,956

    15,038

    TOTAL ASSETS

    863,286

    644,409

    Liabilities and shareholders' equity





    CURRENT LIABILITIES:





    Accounts payable

    13,966

    16,242

    Contract liabilities

    10,923

    13,798

    Other liabilities

    39,247

    51,980

    TOTAL CURRENT LIABILITIES

    64,136

    82,020

        NON-CURRENT LIABILITIES:





    Contract liabilities

    3,766

    3,959

    Other liabilities

    1,399

    303

    Operating lease liabilities

    6,613

    3,509

    TOTAL NON-CURRENT LIABILITIES

    11,778

    7,771

    TOTAL LIABILITIES

    75,914

    89,791







    TOTAL SHAREHOLDERS' EQUITY

    787,372

    554,618

    TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

    863,286

    644,409

     

     

    INMODE LTD.

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (U.S. dollars in thousands, except for per share data)

    (Unaudited)







    Three months ended

    December 31,

    Year Ended

    December 31,



    2023

    2022

    2023

    2022



    CASH FLOWS FROM OPERATING ACTIVITIES:











    Net income

    55,165

    37,708

    197,919

    161,520



    Adjustments required to reconcile net income to net cash provided by operating activities:











    Depreciation and amortization

    122

    218

    623

    680



    Share-based compensation expenses

    6,322

    7,148

    23,600

    24,452



    Allowance for doubtful accounts

    355

    47

    1,020

    449



    Loss on marketable securities, net

    -

    22

    -

    71



    Finance expenses (income), net

    (1,581)

    (2,737)

    (4,714)

    (1,210)



    Deferred income taxes, net

    (30)

    (72)

    (184)

    84



    Changes in operating assets and liabilities:











    Decrease (increase) in accounts receivable

    377

    805

    (16,084)

    (10,415)



    Decrease (increase) in other receivables

    3,143

    (1,081)

    (2,224)

    (1,787)



    Increase in inventories

    (5,106)

    (4,087)

    (5,198)

    (18,871)



    Increase (decrease) in accounts payable

    1,633

    2,946

    (2,276)

    7,463



    Increase (decrease) in other liabilities

    204

    14,575

    (12,588)

    17,941



    Increase (decrease) in contract liabilities

    562

    1,660

    (3,068)

    1,201



    Net cash provided by operating activities

    61,166

    57,152

    176,826

    181,578



    CASH FLOWS FROM INVESTING ACTIVITIES:











    Investment in short-term deposits

    (67,101)

    -

    (233,241)

    (93,701)



    Proceeds from short-term deposits

    -

    -

    85,090

    73,090



    Purchase of fixed assets

    (21)

    (328)

    (705)

    (1,575)



    Other investments

    (100)

    -

    (100)

    -



    Purchase of marketable securities

    (52,527)

    (70,944)

    (245,337)

    (168,680)



    Proceeds from sale of marketable securities

    5,000

    -

    5,000

    2,303



    Proceeds from maturity of marketable securities

    63,159

    32,997

    253,229

    79,089



    Net cash used in investing activities

    (51,590)

    (38,275)

    (136,064)

    (109,474)



    CASH FLOWS FROM FINANCING ACTIVITIES:











    Repurchase of ordinary shares

    -

    -

    -

    (42,637)



         Exercise of options

    275

    637

    5,504

    1,552



    Net cash provided by (used in) financing activities

    275

    637

    5,504

    (41,085)



    EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS

    827

    978

    605

    (1,615)



    NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

    10,678

    20,492

    46,871

    29,404



    CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD

    133,733

    77,048

    97,540

    68,136



    CASH AND CASH EQUIVALENTS AT END OF PERIOD

    144,411

    97,540

    144,411

    97,540



     

     

    INMODE LTD.

    CONDENSED CONSOLIDATED FINANCIAL HIGHLIGHTS

    (U.S. dollars in thousands, except for per share data)

    (Unaudited)





    Three months ended

    December 31,

    Year ended

    December 31,

    2023

    2022

    2023

    2022

    Revenues by Category:



































    Capital Equipment revenues - United States

    69,253

    55 %

    80,352

    60 %

    260,801

    53 %

    260,992

    58 %

    Capital Equipment revenues - International

    37,004

    29 %

    36,094

    27 %

    151,288

    31 %

    133,220

    29 %

    Total Capital Equipment revenues

    106,257

    84 %

    116,446

    87 %

    412,089

    84 %

    394,212

    87 %

    Consumables and service revenues

    20,524

    16 %

    17,125

    13 %

    79,959

    16 %

    60,059

    13 %

    Total Net Revenue

    126,781

    100 %

    133,571

    100 %

    492,048

    100 %

    454,271

    100 %

     

     



    Three months ended December 31,

    Year ended December 31,

    2023

    2022

    2023

    2022



    %

    %

    %

    %



    United States

    International

    Total

    United States

    International

    Total

    United States

    International

    Total

    United States

    International

    Total

    Revenues by Technology:

























    Minimal-Invasive

    84

    80

    83

    86

    76

    83

    86

    77

    83

    85

    74

    81

    Hands-Free

    12

    4

    9

    11

    4

    9

    11

    5

    8

    12

    6

    10

    Non-Invasive

    4

    16

    8

    3

    20

    8

    3

    18

    9

    3

    20

    9



    100

    100

    100

    100

    100

    100

    100

    100

    100

    100

    100

    100

     

     

    INMODE LTD.

    RECONCILIATION OF GAAP CONDENSED CONSOLIDATED STATEMENTS OF

     INCOME TO NON-GAAP CONDENSED CONSOLIDATED STATEMENTS OF INCOME 

    (U.S. dollars in thousands, except for per share data)

    (Unaudited)





    Three months ended December 31, 2023

    Three months ended December 31, 2022

    GAAP

    Share Based Compensation

    Non-GAAP

    GAAP

    Share Based Compensation

    Undistributed Exempt Income

    Non-GAAP

    REVENUES

    126,781

    -

    126,781

    133,571

    -

    -

    133,571

    COST OF REVENUES

    20,264

    (573)

    19,691

    21,002

    (553)

    -

    20,449

    GROSS PROFIT

    106,517

    573

    107,090

    112,569

    553



    113,122

    OPERATING EXPENSES:















    Research and development

    3,473

    (665)

    2,808

    3,261

    (918)

    -

    2,343

    Sales and marketing

    49,451

    (4,611)

    44,840

    47,012

    (5,069)

    -

    41,943

    General and administrative

    2,349

    (473)

    1,876

    2,398

    (608)

    -

    1,790

    TOTAL OPERATING

    EXPENSES

    55,273

    (5,749)

    49,524

    52,671

    (6,595)

    -

    46,076

    INCOME FROM OPERATIONS

    51,244

    6,322

    57,566

    59,898

    7,148



    67,046

    Finance income, net

     

    8,920

    -

    8,920

    3,962

    -

    -

    3,962

    INCOME BEFORE TAXES

    60,164

    6,322

    66,486

    63,860

    7,148



    71,008

    INCOME TAXES

    4,999

    -

    4,999

    26,152

    -

    (21,514)

    4,638

    NET INCOME

    55,165

    6,322

    61,487

    37,708

    7,148

    21,514

    66,370

















    NET INCOME PER SHARE:















    Basic

    0.66



    0.73

    0.46





    0.80

    Diluted

    0.64



    0.71

    0.44





    0.78

    WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF NET INCOME PER SHARE (in thousands)















    Basic

    83,862



    83,862

    82,449





    82,449

    Diluted

    85,835



    86,196

    85,288





    85,515

     

     

    INMODE LTD.

    RECONCILIATION OF GAAP CONDENSED CONSOLIDATED STATEMENTS OF

     INCOME TO NON-GAAP CONDENSED CONSOLIDATED STATEMENTS OF INCOME 

    (U.S. dollars in thousands, except for per share data)

    (Unaudited)





    Year Ended December 31, 2023

    Year Ended December 31, 2022



    GAAP

    Share Based

    Compensation

    Non-GAAP

    GAAP

    Share Based

    Compensation

    Undistributed Exempt Income

    Non-GAAP

    REVENUES

    492,048

    -

    492,048

    454,271

    -

    -

    454,271

    COST OF REVENUES

    80,708

    (2,046)

    78,662

    73,485

    (1,917)

    -

    71,568

    GROSS PROFIT

    411,340

    2,046

    413,386

    380,786

    1,917

    -

    382,703

    OPERATING EXPENSES:















    Research and development

    13,410

    (2,652)

    10,758

    12,425

    (3,166)

    -

    9,259

    Sales and marketing

    193,042

    (17,167)

    175,875

    160,576

    (17,302)

    -

    143,274

    General and administrative

    9,228

    (1,735)

    7,493

    9,931

    (2,067)

    -

    7,864

    TOTAL OPERATING

    EXPENSES

    215,680

    (21,554)

    194,126

    182,932

    (22,535)

    -

    160,397

    INCOME FROM OPERATIONS

    195,660

    23,600

    219,260

    197,854

    24,452

    -

    222,306

    Finance income, net

    21,607

    -

    21,607

    3,612

    -

    -

    3,612

    INCOME BEFORE TAXES

    217,267

    23,600

    240,867

    201,466

    24,452

    -

    225,918

    INCOME TAXES (TAX BENEFIT)

    19,348

    -

    19,348

    39,946

    -

    (21,514)

    18,432

    NET INCOME

    197,919

    23,600

    221,519

    161,520

    24,452

    21,514

    207,486

















    NET INCOME PER

    SHARE:















    Basic

    2.37



    2.65

    1.96





    2.52

    Diluted

    2.30



    2.57

    1.89





    2.42

    WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF NET INCOME PER SHARE (in thousands)















    Basic

    83,534



    83,534

    82,482





    82,482

    Diluted

    85,954



    86,177

    85,404





    85,628





















     

    Logo - https://mma.prnewswire.com/media/1064477/InMode_Logo.jpg

    Cision View original content:https://www.prnewswire.com/news-releases/inmode-reports-fourth-quarter-and-full-year-2023-financial-results-quarterly-revenue-of-126-8m-and-record-full-year-revenue-of-492m-302060046.html

    SOURCE InMode LTD

    Get the next $INMD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $INMD

    DatePrice TargetRatingAnalyst
    4/29/2025Buy → Neutral
    BTIG Research
    4/28/2025$22.00 → $16.00Outperform → Neutral
    Robert W. Baird
    10/17/2024$25.00Buy
    BTIG Research
    7/23/2024$21.00 → $19.00Buy → Hold
    Jefferies
    11/3/2023$52.00 → $24.00Buy → Neutral
    UBS
    10/13/2023$55.00 → $22.00Buy → Hold
    Canaccord Genuity
    3/29/2023$40.00Buy
    UBS
    2/17/2023Buy → Hold
    Needham
    More analyst ratings

    $INMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    InMode to Report First Quarter 2026 Financial Results and Hold Conference Call on May 6, 2026, Expects Q1 Revenue Between $81.5M-$81.7M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M

    Conference call to be held on Wednesday, May 6, 2026, at 8:30 a.m. Eastern TimeYOKNEAM, Israel, April 13, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the first quarter of 2026 before the Nasdaq market opens on Wednesday, May 6, 2026. InMode is currently finalizing its financial results for the first quarter of 2026. While complete financial information and operating data are not yet available, set forth below are certain preliminary results of I

    4/13/26 7:00:00 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    InMode to Present at the 25th Annual Needham Virtual Healthcare Conference

    YOKNEAM, Israel, March 24, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD), a leading global provider of innovative medical technologies, today announced that Moshe Mizrahy, Chief Executive Officer and Yair Malca, Chief Financial Officer will present at the 25th Annual Needham Virtual Healthcare Conference on Monday, April 13, 2026. The fireside chat, moderated by Michael Matson, Senior Equity Analyst, is scheduled for 11:00 am Eastern Time on Monday, April 13, and a live webcast of the presentation can be accessed here. InMode will also hold virtual one-on-one investor meetings

    3/24/26 8:30:00 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    InMode Announces New Share Repurchase Program

    YOKNEAM, Israel, March 13, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that its Board of Directors has authorized a new share repurchase program for up to approximately 10% of the Company's total shares outstanding, representing approximately 6.38 million ordinary shares. In 2025, the Company repurchased approximately $127.4 million of its outstanding ordinary shares through share repurchase programs. Despite a challenging macroeconomic environment, the Company continues to generate strong cash fl

    3/13/26 7:00:00 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $INMD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by InMode Ltd.

    3 - InMode Ltd. (0001742692) (Issuer)

    3/18/26 7:09:10 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 3 filed by InMode Ltd.

    3 - InMode Ltd. (0001742692) (Issuer)

    3/18/26 7:06:52 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 3 filed by new insider Mizrahy Moshe

    3 - InMode Ltd. (0001742692) (Issuer)

    3/18/26 7:08:06 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $INMD
    SEC Filings

    View All

    SEC Form 6-K filed by InMode Ltd.

    6-K - InMode Ltd. (0001742692) (Filer)

    3/13/26 7:00:09 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 6-K filed by InMode Ltd.

    6-K - InMode Ltd. (0001742692) (Filer)

    2/23/26 7:00:19 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form S-8 filed by InMode Ltd.

    S-8 - InMode Ltd. (0001742692) (Filer)

    2/10/26 7:38:08 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $INMD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    InMode downgraded by BTIG Research

    BTIG Research downgraded InMode from Buy to Neutral

    4/29/25 8:06:22 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    InMode downgraded by Robert W. Baird with a new price target

    Robert W. Baird downgraded InMode from Outperform to Neutral and set a new price target of $16.00 from $22.00 previously

    4/28/25 1:56:11 PM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    BTIG Research initiated coverage on InMode with a new price target

    BTIG Research initiated coverage of InMode with a rating of Buy and set a new price target of $25.00

    10/17/24 7:41:34 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $INMD
    Financials

    Live finance-specific insights

    View All

    InMode to Report First Quarter 2026 Financial Results and Hold Conference Call on May 6, 2026, Expects Q1 Revenue Between $81.5M-$81.7M, Reiterates FY 2026 Revenue Guidance Between $365M-$375M

    Conference call to be held on Wednesday, May 6, 2026, at 8:30 a.m. Eastern TimeYOKNEAM, Israel, April 13, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the first quarter of 2026 before the Nasdaq market opens on Wednesday, May 6, 2026. InMode is currently finalizing its financial results for the first quarter of 2026. While complete financial information and operating data are not yet available, set forth below are certain preliminary results of I

    4/13/26 7:00:00 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    InMode Reports Fourth Quarter and Full Year 2025 Financial Results: Quarterly GAAP Revenue of $103.9 Million and Full Year Revenue of $370.5 Million

    YOKNEAM, Israel, Feb. 10, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the fourth quarter and full year of 2025. Fourth Quarter 2025 Highlights: Quarterly GAAP revenues of $103.9 million, compared to $97.9 million in the fourth quarter of 2024.Quarterly revenues from consumables and service of $21.5 million, an increase of 8% compared to the fourth quarter of 2024.GAAP operation income of $26 million, *non-GAAP operation income of $28.5 million.Total cash position of $555.3 million as of December 31, 2025, including cash and cash equivalents, marketable securiti

    2/10/26 7:00:00 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    InMode to Report Fourth Quarter & Full Year 2025 Financial Results and Hold Conference Call on February 10, 2026, Expects Q4 Revenue Between $103.6M-$103.8M

    Conference call to be held on Tuesday, February 10, 2026, at 8:30 a.m. Eastern Time YOKNEAM, Israel, Jan. 8, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the fourth quarter and full year of 2025 before the Nasdaq market opens on Tuesday, February 10, 2026. InMode is currently finalizing its financial results for the fourth quarter and full year of 2025. While complete financial information and operating data are not yet available, set forth below are certain preliminary results of InMode's financial results for such period, subject to final adjustments and ot

    1/8/26 7:00:00 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $INMD
    Leadership Updates

    Live Leadership Updates

    View All

    InMode Appoints Michael Dennison as President of North America

    IRVINE, Calif., Nov. 3, 2025 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD), a leading global provider of innovative medical technologies, has appointed Michael Dennison, most recently Vice President of Sales, as President of North America.  Dennison has held nearly every sales position in the aesthetic medical device industry, consistently producing at the highest level in each. With close to a decade of leadership experience at InMode, Dennison has advanced through roles from District Sales Manager to Vice President of Sales, driving national revenue growth, expanding market shar

    11/3/25 8:05:00 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $INMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by InMode Ltd. (Amendment)

    SC 13G/A - InMode Ltd. (0001742692) (Subject)

    2/13/24 4:31:18 PM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SC 13G/A filed by InMode Ltd. (Amendment)

    SC 13G/A - InMode Ltd. (0001742692) (Subject)

    2/13/24 4:25:40 PM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SC 13G filed by InMode Ltd.

    SC 13G - InMode Ltd. (0001742692) (Subject)

    2/6/24 9:36:39 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care